데이터가 없습니다.

1. Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy [ INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER ] - 2023.11.06
2. CD8α+ dendritic cells potentiate antitumor and immune activities against murine ovarian cancers [ SCIENTIFIC REPORTS ] - 2023.01.03
3. Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the Prognosis of Patients with High-Grade Serous Ovarian Cancer [ INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ] - 2021.09.01
4. Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women [ Obstetrics & Gynecology Science ] - 2019.11.01
5. An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy [ INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ] - 2019.10.05
6. Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma [ JOURNAL OF GYNECOLOGIC ONCOLOGY ] - 2019.05.01
7. Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer [ Obstetrics & Gynecology Science ] - 2018.05.01
8. An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021) [ CANCER RESEARCH AND TREATMENT ] - 2018.01.01
9. An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016) [ JOURNAL OF GYNECOLOGIC ONCOLOGY ] - 2017.05.01
10. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement [ JOURNAL OF GYNECOLOGIC ONCOLOGY ] - 2017.01.01
11. Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells [ CANCER RESEARCH ] - 2017.01.01
12. Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers [ JOURNAL OF GYNECOLOGIC ONCOLOGY ] - 2017.01.01

1. 자궁내막암 세포의 성장 및 증식 억제에 대한 디에노게스트(dienogest)의 효용성 평가 - 2023.06.01 ~ 2024.12.31
2. 고위험 난소암 환자에서 혈중 종양 유전자 초고감도 검출 플랫폼 (OncoUHS) 구축 및 임상적 유용성 평가 - 2023.03.01 ~ 2024.02.29
3. PARP inhibitor로 치료받은 적이 있는 백금 저항성, 진행성_재발성 난소암 환자에서 PARP_TNKS dual inhibitor인 JPI-547의 유효성 및 안전성을 평가하기 위한 다기관, 공개, 단일군, 제2상 임상시험 - 2022.09.22 ~ 2025.06.30
4. 고위험 난소암 환자에서 혈중 종양 유전자 초고감도 검출 플랫폼 (OncoUHS) 구축 및 임상적 유용성 평가 - 2022.03.01 ~ 2023.02.28
5. 고위험 난소암 환자에서 혈중 종양 유전자 초고감도 검출 플랫폼 (OncoUHS) 구축 및 임상적 유용성 평가 - 2021.06.01 ~ 2022.02.28
6. 난소암 자궁 경부 투명세포암 환자의 예후인자 분석 - 2019.01.01 ~ 2020.12.31
7. 차세대 시퀀싱을 통한 병인성 유전체돌연변이 확인 및 순환종양유전자를 이용한 상피성 난소암 환자의 맞춤형 모니터링 시스템 개발 및 효용성 확인 - 2018.06.21 ~ 2020.03.31
8. 순환종양유전자를 이용한 상피성 난소암 환자의 맞춤형 모니터링 시스템 개발 및 효용성 확인 - 2018.01.01 ~ 2018.12.31

데이터가 없습니다.

      데이터가 없습니다.

 공지